Literature DB >> 10480466

Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic Black Americans.

S Humphries1, H Kushner, B Falkner.   

Abstract

In both humans and experimental animals, dietary induced magnesium deficiency is correlated with insulin resistance. The purpose of this study was to determine whether dietary magnesium intake is associated with insulin sensitivity or blood pressure in a sample of nondiabetic, young adult black Americans. We also examined dietary calcium, potassium, and sodium intake. The study was conducted on a sample (n = 179) of young adults aged 30 +/- 3.4 years who had been followed longitudinally. Nutrient intake was assessed by obtaining a 24-h recall interview of dietary intake. Intake data were entered in a nutrient analysis program (Nutritionist III), which quantitated micronutrients, macronutrients, and minerals. We classified the sample into insulin-sensitive (IS) and insulin-resistant (IR) groups, according to insulin-stimulated glucose use (M) measured during insulin clamp. M correlated positively with magnesium intake in mg/kg of fat-free mass (r = 0.15, P < .05 overall; in men, r = 0.25, P < .02). There was a significant negative correlation of total dietary magnesium intake with the sum of insulin levels measured during an oral glucose tolerance test (OGTT) (r = -0.13, P < .05). When corrected for body fat, in men there was also a significant correlation of dietary magnesium intake, measured in mg/kg of fat-free mass, with the sum of insulin concentrations on the OGTT (r = -0.22, P < .05). When cases were categorically classified as IS versus IR, magnesium intake in mg/kg of fat-free mass was lower in IR (2.97 +/- 1.4) than in IS (3.68 +/- 2.2; P = .022). These results suggest a possible role for dietary magnesium in insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480466     DOI: 10.1016/s0895-7061(99)00041-2

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  17 in total

1.  Higher magnesium intake is associated with lower fasting glucose and insulin, with no evidence of interaction with select genetic loci, in a meta-analysis of 15 CHARGE Consortium Studies.

Authors:  Adela Hruby; Julius S Ngwa; Frida Renström; Mary K Wojczynski; Andrea Ganna; Göran Hallmans; Denise K Houston; Paul F Jacques; Stavroula Kanoni; Terho Lehtimäki; Rozenn N Lemaitre; Ani Manichaikul; Kari E North; Ioanna Ntalla; Emily Sonestedt; Toshiko Tanaka; Frank J A van Rooij; Stefania Bandinelli; Luc Djoussé; Efi Grigoriou; Ingegerd Johansson; Kurt K Lohman; James S Pankow; Olli T Raitakari; Ulf Riserus; Mary Yannakoulia; M Carola Zillikens; Neelam Hassanali; Yongmei Liu; Dariush Mozaffarian; Constantina Papoutsakis; Ann-Christine Syvänen; André G Uitterlinden; Jorma Viikari; Christopher J Groves; Albert Hofman; Lars Lind; Mark I McCarthy; Vera Mikkilä; Kenneth Mukamal; Oscar H Franco; Ingrid B Borecki; L Adrienne Cupples; George V Dedoussis; Luigi Ferrucci; Frank B Hu; Erik Ingelsson; Mika Kähönen; W H Linda Kao; Stephen B Kritchevsky; Marju Orho-Melander; Inga Prokopenko; Jerome I Rotter; David S Siscovick; Jacqueline C M Witteman; Paul W Franks; James B Meigs; Nicola M McKeown; Jennifer A Nettleton
Journal:  J Nutr       Date:  2013-01-23       Impact factor: 4.798

2.  Increase in serum magnesium level in haemodialysis patients receiving sevelamer hydrochloride.

Authors:  Efstathios Mitsopoulos; Ioannis Griveas; Stavros Zanos; Konstantinos Anagnostopoulos; Anastasia Giannakou; Aikaterini Pavlitou; Georgios Sakellariou
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 3.  Metabolic acidosis-induced insulin resistance and cardiovascular risk.

Authors:  Gema Souto; Cristóbal Donapetry; Jesús Calviño; Maria M Adeva
Journal:  Metab Syndr Relat Disord       Date:  2011-02-25       Impact factor: 1.894

4.  Promotion and selection by serum growth factors drive field cancerization, which is anticipated in vivo by type 2 diabetes and obesity.

Authors:  Harry Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-01       Impact factor: 11.205

Review 5.  Magnesium and type 2 diabetes.

Authors:  Mario Barbagallo; Ligia J Dominguez
Journal:  World J Diabetes       Date:  2015-08-25

Review 6.  Magnesium deficiency in African-Americans: does it contribute to increased cardiovascular risk factors?

Authors:  Chester H Fox; Martin C Mahoney; Delano Ramsoomair; Cathleen A Carter
Journal:  J Natl Med Assoc       Date:  2003-04       Impact factor: 1.798

Review 7.  Neurodegeneration as a primary change and role of neuroprotection in diabetic retinopathy.

Authors:  Vishal Jindal
Journal:  Mol Neurobiol       Date:  2014-05-15       Impact factor: 5.590

8.  Does long-term coffee intake reduce type 2 diabetes mellitus risk?

Authors:  Gustavo D Pimentel; Juliane Cs Zemdegs; Joyce A Theodoro; João F Mota
Journal:  Diabetol Metab Syndr       Date:  2009-09-16       Impact factor: 3.320

Review 9.  Risk Factors for Cholelithiasis.

Authors:  Mila Pak; Glenda Lindseth
Journal:  Gastroenterol Nurs       Date:  2016 Jul-Aug       Impact factor: 0.978

Review 10.  Dietary magnesium and genetic interactions in diabetes and related risk factors: a brief overview of current knowledge.

Authors:  Adela Hruby; Nicola M McKeown; Yiqing Song; Luc Djoussé
Journal:  Nutrients       Date:  2013-12-06       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.